Alpa Laboratories Limited

NSEI:ALPA Stock Report

Market Cap: ₹2.5b

Alpa Laboratories Balance Sheet Health

Financial Health criteria checks 5/6

Alpa Laboratories has a total shareholder equity of ₹1.5B and total debt of ₹52.5M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are ₹1.8B and ₹304.6M respectively. Alpa Laboratories's EBIT is ₹56.3M making its interest coverage ratio 15.8. It has cash and short-term investments of ₹928.5M.

Key information

3.5%

Debt to equity ratio

₹52.47m

Debt

Interest coverage ratio15.8x
Cash₹928.54m
Equity₹1.52b
Total liabilities₹304.62m
Total assets₹1.82b

Recent financial health updates

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Recent updates

Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Sep 22
Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

Sep 06
Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Aug 26
Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Jun 17
Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24
Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05
Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31
Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28
With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Financial Position Analysis

Short Term Liabilities: ALPA's short term assets (₹1.6B) exceed its short term liabilities (₹280.7M).

Long Term Liabilities: ALPA's short term assets (₹1.6B) exceed its long term liabilities (₹24.0M).

Debt to Equity History and Analysis

Debt Level: ALPA has more cash than its total debt.

Reducing Debt: ALPA's debt to equity ratio has increased from 1% to 3.5% over the past 5 years.

Debt Coverage: ALPA's debt is well covered by operating cash flow (69.5%).

Interest Coverage: ALPA's interest payments on its debt are well covered by EBIT (15.8x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y